Tablet formation
    2.
    发明授权
    Tablet formation 有权
    片剂形成

    公开(公告)号:US07108864B1

    公开(公告)日:2006-09-19

    申请号:US09656364

    申请日:2000-09-06

    IPC分类号: A61K9/20

    CPC分类号: A61K9/2054 A61K31/496

    摘要: Disclosed is a non-sustained release pharmaceutical tablet composition which comprises a rapidly precipitating drug in an amount from about 5 to about 60% and at least one member selected from the group consisting of a binder in an amount of from about 2 to about 25% and a superdisintegrant in an amount from about 6 to about 40% where the rapidly precipitating drug, “binder” and superdisintegrant are mixed and compressed into a tablet without heating, solvent or grinding.

    摘要翻译: 公开了一种非持续释放的药物片剂组合物,其包含约5至约60%的快速沉淀药物和至少一种选自约2至约25%的粘合剂的组分, 和超弹性剂,其量为约6至约40%,其中将快速沉淀的药物“粘合剂”和超级崩解剂混合并压片成片而不加热,溶剂或研磨。

    Delavirdine high strength tablet formulation
    6.
    发明授权
    Delavirdine high strength tablet formulation 有权
    Delavirdine高强度片剂配方

    公开(公告)号:US06177101B1

    公开(公告)日:2001-01-23

    申请号:US09327135

    申请日:1999-06-07

    IPC分类号: A61K920

    CPC分类号: A61K9/2054 A61K31/496

    摘要: Disclosed is a non-sustained release pharmaceutical tablet composition which comprises a rapidly precipitating drug in an amount from about 5 to about 60% and at least one member selected from the group consisting of a binder in an amount of from about 2 to about 25% and a superdisintegrant in an amount from about 6 to about 40% where the rapidly precipitating drug, “binder” and superdisintegrant are mixed and compressed into a tablet without heating, solvent or grinding.

    摘要翻译: 公开了一种非持续释放的药物片剂组合物,其包含约5至约60%的快速沉淀药物和至少一种选自约2至约25%的粘合剂的组分, 和超弹性剂,其量为约6至约40%,其中将快速沉淀的药物“粘合剂”和超级崩解剂混合并压片成片而不加热,溶剂或研磨。